The effects of fluoxetine combined with nicotine inhalers in smoking cessation - A randomized trial

Addiction

Volumn 94, Issue 7, 1999, Pages 1007-1015

  Blondal, Thorsteinn ^a   Gudmundsson, Larus J ^b   Tomasson, Kristinn ^b   Jonsdottir, Dagmar ^b   Hilmarsdottir, Holmfridur ^b   Kristjansson, Fjalar ^b   Nilsson, Fredrik ^b   Bjornsdottir, Unnur Steina ^b  

^a Reykjavik Health Care Center   (Iceland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NICOTINE;

ABSTINENCE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; INHALER; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMOKING CESSATION; SUBSTITUTION THERAPY; TIME; TREATMENT OUTCOME;

EID: 0032776493     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1999.94710076.x     Document Type: Article

References (24)

1. 1. HALL, S. M., MUNOZ, R. F., REUS, V. I. & SEES, K. L. (1993) Nicotine, negative affect, and depression, Journal of Consulting and Clinical Psychology, 61, 761-767.
2. 2. COVEY, L. S., GLASSMAN, A. H. & STETNER, F. (1998) Cigarette smoking and major depression, Journal of Addictive Diseases, 17, 35-46.
3. 3. BRESLAU, N. (1995) Psychiatric comorbidity of smoking and nicotine dependence, Behavior Genetics, 2, 95-101.
4. 4. WANG, M. Q., FITZHUGH, E. C., WESTERFIELD, R. C. & EDDY, J. M. (1994) Predicting smoking status by symptoms of depression for U.S. adolescents, Psychological Reports, 75, 911-914.
5. 5. ANDA, R. F., WILLIAMSON, D. F., ESCOBEDO, L. G., NAST, E. E., GIOVINO, G. A. & REMINGTON, P. L. (1990) Depression and the dynamics of smoking: a national perspective, Journal of the American Medical Association, 264, 1541-1545.
6. 6. SILAGY, C., MANT, D., FOWLER, G. & LODGE, M. (1994) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation, Lancet, 343, 139-142.
7. 7. HUGHES, J. R., STEAD, L. F. & LANCASTER, T. R. (1998) Anxiolytics and antidepressants in smoking cessation (Cochrane Review), in: The Cochrane Library, issue 2, updated quarterly (Oxford, Update Software).
8. 8. HURT, R. D., SACHS, D. P. L., GLOVER, E. D. et al. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation, New England Journal of Medicine, 337, 1195-1202.
9. 9. GRAM, L. F. (1994) Fluoxetine, New England Journal of Medicine, 331, 1354-1361.
10. 10. DALACK, G. W., GLASSMAN, A. H., RIVELLI, S. B. A., COVEY, L. & STETNER, F. (1995) Mood, major depression, and fluoxetine response in cigarette smokers, American Journal of Psychiatry, 152, 398-403.
11. 11. TOØNNESEN, P., NØRREGAARD, J., MlKKELSEN, K., JORGENSEN, S. & NILSSON, F. (1993) A double-blind trial of a nicotine inhaler for smoking cessation, Journal of the American Medical Association, 269, 1268-1271.
12. 12. FEIGHNER, J. P., BOYER, W. F., MERIDETH, C. H. & HENDRICKSON, G. G. (1989) A double blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression, International Clinical Psychopharmacology, 4, 127-134.
13. 13. DUNLOP, S. R., DORNSEIF, B. E., WERNICKE, J. F. & POTVIN, J. H. (1990) Pattern analysing shows beneficial effect of fluoxetine treatment in mild depression, Psychopharmacology Bulletin, 26, 173-180.
14. 14. HEATHERTON, T. F., KOZLOWSKI, T. L., FRECKER, R. C. & FAGERSTRÖM, K. O. (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire, British Journal of Addiction, 86, 1119-1127.
15. 15. BECK, A. T., WARD, C. H., MENDELSON, M., MOCK, J. & ERBAUGH, J. (1961) An inventory for measuring depression, Archives of General Psychiatry, 4, 561-571.
16. 16. TASK FORCE ON DSM-IV (1994) Diagnostic and Statistical Manual of Mental Disorders (Washington, DC, American Psychiatric Association).
17. 17. FALKMAN, S, E., BURROWS, I. E., LUNDGREN, R. A. & PAGE, B. F. J. (1975) A modified procedure for determination for nicotine in blood, Analyst, 100, 99-104.
18. 18. ORSULAK, P. J., KENNEY, J. T., DEBUS, J. R., CROWLEY, G. & WITTMAN, P. D. (1988) Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC, with ultraviolet detection, Clinical Chemistry, 34, 1875-1878.
19. 19. JARVIS, M. J., TUNSTALL-PEDOE, H., FEYERABEND, C., VESEY, C. & SALOOJEE, Y. (1987) Comparison of tests used to distinguish smokers from non-smokers, American Journal of Public Health, 77, 1435-1430.
20. 20. BLONDAL, T., FRANZON, M. & WESTIN, A. (1997) A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation, European Respiratory Journal, 10, 1585-1590.
21. 21. HOSMER, D. W. & LEMESHOW, S. (1989) Applied Logistic Regression (New York, John Wiley and Sons).
22. 22. PONTIERI, F. E., TANDA, G., ORZI, F. & CHIARA, G. D. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs, Nature, 382, 255-257.
23. 23. STOLERMAN, I. P., MIRZA, N. R. & SHOAIB, M. (1995) Nicotine psychopharmacology: addiction, cognition and neuroadaptation, Medicinal Research Reviews, 15, 47-72.
24. 24. MURPHY, D. L., ANDREWS, A. M., WICHEMS, C. H., LI, Q., TOHDA, M. & GREENBERG, B. (1998) Brain serotonin transmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs, Journal of Clinical Psychiatry, 59 (suppl. 15), 4-12.